Sanofi Sunrise Co. MyoKardia Sets Heart On Untapped Cardiomyopathy Market

Emerging Company Profile: MyoKardia, a company backed by Sanofi's Sunrise initiative, has big development plans for the first therapeutic treatment targeting the root cause of hypertrophic cardiomyopathy – a chronic, progressive form of heart failure.